1-2 of 2
Peter Tarassoff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Report of a Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Decitabine As an Epigenetic Priming Agent When Combined with Induction Chemotherapy in Pediatric Patients (pts) with Newly Diagnosed Acute Myelogenous Leukemia (AML)

Free
Lia Gore, MD, Margaret E. Macy, M.D., Francoise Mechinaud, MD, Aru Narendran, MD, PhD, Frank Alvaro, MD, Carola A.S. Arndt, MD, Phillip Barnette, MD, Jessica Boklan, MD, Todd Cooper, DO, Laura Martin, MD, W Tcheng, MD, Peter Tarassoff, MD, Mark M Jones, MD, Soheil Meshinchi, MD, PhD, Robert J. Arceci, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1517.
https://doi.org/10.1182/blood.V120.21.1517.1517
Published: 2012
Journal Articles

A Phase 1 Study to Assess the Absolute Bioavailability and Safety of An Oral Solution of Decitabine In Subjects with Myelodysplastic Syndromes (MDS),

Free
Bipin Mistry, Ph.D., Mark M Jones, MD, Peter Kubiak, Ph.D., Guillermo Garcia-Manero, Mark R. Litzow, MD, Ruben A. Mesa, MD, Robert Rifkin, MD, Peter Tarassoff, MD, Ph.D., Jorge E. Cortes
Journal: Blood
Blood (2011) 118 (21): 3801.
https://doi.org/10.1182/blood.V118.21.3801.3801
Published: 2011